Organic anion transporter OAT1 is involved in renal handling of citrulline

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 1, 2009, Pages

  Nakakariya, Masanori ^a   Shima, Yoichiro ^a   Shirasaka, Yoshiyuki ^a,b   Mitsuoka, Keisuke ^b   Nakanishi, Takeo ^b   Tamai, Ikumi ^a,b  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Biomarker; Creatinine; Glomerular filtration rate; Renal failure

Indexed keywords

CITRULLINE; CREATININE; DICARBOXYLATE TRANSPORTER; GLUTARIC ACID; ORGANIC ANION TRANSPORTER 1; POLYCYCLIC AROMATIC HYDROCARBON; PROBENECID;

ANIMAL CELL; ANIMAL TISSUE; ANION TRANSPORT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY SLICE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 67650683720     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90662.2008     Document Type: Article

References (34)

1. Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol 55: 847-854, 1999.
2. Bouby N, Hassler C, Parvy P, Bankir L. Renal synthesis of arginine in chronic renal failure: in vivo and in vitro studies in rats with 5?6 nephrectomy. Kidney Int 44: 676-683, 1993.
3. Chauveau P, Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, Jungers P. Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab 18: 196-198, 1992.
4. Deguchi T, Takemoto M, Uehara N, Lindup WE, Suenaga A, Otagiri M. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. J Pharmacol Exp Ther 314: 932-938, 2005.
5. Dettli L. Drug dosage in renal disease. Clin Pharmacokinet 1: 126-134, 1976.
6. Habu Y, Yano I, Hashimoto Y, Saito H, Inui K. p-Aminohippurate transport at the apical membrane in the OK kidney epithelial cell line. Pharm Res 19: 1822-1826, 2002.
7. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther 305: 1087-1097, 2003.
8. Ishiguro N, Saito A, Yokoyama K, Morikawa M, Igarashi T, Tamai I. Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. Drug Metab Dispos 33: 495-499, 2005.
9. Ito K, Koresawa T, Nakano K, Horie T. Mrp2 is involved in benzylpenicillin-induced choleresis. Am J Physiol Gastrointest Liver Physiol 287: G42-G49, 2004.
10. Jung KY, Takeda M, Shimoda M, Narikawa S, Tojo A, Kim DK, Chairoungdua A, Choi BK, Kusuhara H, Sugiyama Y, Sekine T, Endou H. Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci 70: 1861-1874, 2002.
11. Kihlberg R, Sterner G, Wennberg A, Denneberg T. Plasma free amino acid levels in uremic rats given high and low protein diets or intravenous infusions of amino acid solutions. J Nutr 112: 2058-2070, 1982.
12. Kopple JD. Abnormal amino acid and protein metabolism in uremia. Kidney Int 14: 340-348, 1978.
13. Levillain O, Parvy P, Hassler C. Amino acid handling in uremic rats: citrulline, a reliable marker of renal insufficiency and proximal tubular dysfunction. Metabolism 46: 611-618, 1997.
14. Matsumoto S, Yoshida K, Ishiguro N, Maeda T, Tamai I. Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]. J Pharmacol Exp Ther 322: 1246-1252, 2007.
15. Mizuno N, Takahashi T, Iwase Y, Kusuhara H, Niwa T, Sugiyama Y. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos 35: 1429-1434, 2007.
16. Torres A, Laughlin M, Muller A, Brandoni A, Anzai N, Endou H. Altered renal elimination of organic anions in rats with chronic renal failure. Biochim Biophys Acta 1740: 29-37, 2005.
17. Nagai J, Takano M, Hirozane K, Yasuhara M, Inui K. Specificity of p-aminohippurate transport system in the OK kidney epithelial cell line. J Pharmacol Exp Ther 274: 1161-1166, 1995.
18. Nakakariya M, Shimada H, Irokawa M, Maeda T, Tamai I. Identification and species similarity of OATP transporters responsible for hepatic uptake of β-lactam antibiotics. Drug Metab Pharmacokinet 23: 347-355, 2008.
19. Nakakariya M, Shimada T, Irokawa M, Koibuchi H, Iwanaga T, Yabuuchi H, Maeda T, Tamai I. Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics. Pharm Res 25: 578-585, 2008.
20. Ohashi R, Tamai I, Inano A, Katsura M, Sai Y, Nezu J, Tsuji A. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein. J Pharmacol Exp Ther 302: 1286-1294, 2002.
21. Pritchard JB. Coupled transport of p-aminohippurate by rat kidney basolateral membrane vesicles. Am J Physiol Renal Fluid Electrolyte Physiol 255: F597-F604, 1988.
22. Pritchard JB. Rat renal cortical slices demonstrate p-aminohippurate/glutarate exchange and sodium/glutarate coupled p-aminohippurate transport. J Pharmacol Exp Ther 255: 969-975, 1990.
23. Sakurai Y, Motohashi H, Ueo H, Masuda S, Saito H, Okuda M, Mori N, Matsuura M, Doi T, Fukatsu A, Ogawa O, Inui K. Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res 21: 61-67, 2004.
24. Sakurai Y, Motohashi H, Ogasawara K, Terada T, Masuda S, Katsura T, Mori N, Matsuura M, Doi T, Fukatsu A, Inui K. Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis. Pharm Res 22: 2016-2022, 2005.
25. Sato M, Iwanaga T, Mamada H, Ogihara T, Yabuuchi H, Maeda T, Tamai I. Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res 25: 639-646, 2008.
26. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of paraaminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 292: F1599-F1605, 2007.
27. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28: 830-838, 1985.
28. + of p-aminohippuric acid uptake into rat renal basolateral membrane vesicles. Am J Physiol Renal Fluid Electrolyte Physiol 253: F795-F801, 1987.
29. Sugiyama D, Kusuhara H, Shitara Y, Abe T, Sugiyama Y. Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. Drug Metab Dispos 30: 220-223, 2002.
30. Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, Tsuji A. Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res 18: 1262-1269, 2001.
31. Tett SE, Kirkpatrick CM, Gross AS, McLachlan AJ. Principles and clinical application of assessing alterations in renal elimination pathways. Clin Pharmacokinet 42: 1193-1211, 2003.
32. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 65: 1162-1173, 1980.
33. Ullrich KJ, Rumrich G, Fritzsch G, Kloss S. Contraluminal paraaminohippurate (PAH) transport in the proximal tubule of the rat kidney. II. Specificity: aliphatic dicarboxylic acids. Pflügers Arch 408: 38-45, 1987.
34. Uwai Y, Okuda M, Takami K, Hashimoto Y, Inui K. Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett 438: 321-324, 1998.